Merck & Co. is stepping up to the plate to raise awareness of the dangers of high LDL cholesterol and how it can increase the risk of atherosclerotic cardiovascular disease (ASCVD). Joining the New ...

Merck shares were rising early Tuesday in response to positive results from a trial of the heart drug that the company is counting on for much of its growth. Patent protection on Keytruda, the cancer ...

In one of the priciest health care deals of 2025, the pharmaceutical giant Merck has acquired the British drugmaker Verona Pharma, which has its U.S. headquarters in Raleigh, for roughly $10 billion.

The pharmaceutical giant Merck & Co. has announced that it will acquire Verona Pharma for about $10 billion. The deal includes Verona’s Ohtuvayre, a maintenance treatment of chronic obstructive ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Merck & Co. Inc. (NYSE:MRK) agreed on Wednesday to acquire Verona Pharma plc (NASDAQ:VRNA) for $107 per American Depository Share (ADS) for a total transaction value of approximately $10 billion. Each ...

Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing photographed on Friday, Apr. 2, 2021, in Durham, N.C. Casey Toth ctoth@newsobserver.com In one of the biggest health care deals of 2025, ...